Bristol-Myers Squibb

Associate Director, IT Digital Plant & Projects

Indianapolis, Indiana, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Information Technology, PharmaceuticalIndustries

Requirements

Candidates should possess an Associate’s degree or equivalent experience, and a Bachelor’s degree in a related field such as Computer Science, Information Technology, or Engineering is preferred. Strong experience in IT infrastructure, digital plant systems, and project management is required, along with experience in laboratory and process automation systems.

Responsibilities

The Associate Director, IT Digital Plant & Projects will be accountable for continuous operation and maintenance of IT, lab & process automation systems, and associated site infrastructure. They will also lead site service level management scope and process with IT groups and/or vendor managed services, ensuring the Digital Roadmap is leveraged and aligned to business outcomes, driving for value realization, and leading a group of indirect reports and service providers to deliver effective solutions that meet the needs of the site.

Skills

IT infrastructure
Digital plant systems
Project management
Laboratory systems
Process automation systems
Service Level Management
Vendor Managed Services

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Key Metrics

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI